z-logo
open-access-imgOpen Access
Reworsening of Recurrent Guillain-Barré Syndrome Triggered by COVID-19 Infection
Author(s) -
Gian Luca Vita,
Carmen Terranova,
Maria Sframeli,
Antonio Toscano,
Giuseppe Vita
Publication year - 2021
Publication title -
the open neurology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.329
H-Index - 16
ISSN - 1874-205X
DOI - 10.2174/1874205x02115010048
Subject(s) - guillain barre syndrome , medicine , polyradiculoneuropathy , covid-19 , pandemic , vaccination , immunology , pediatrics , viral infection , virus , disease , infectious disease (medical specialty)
Guillain-Barré Syndrome (GBS) is an acute, immune-mediated, generalized polyradiculoneuropathy often triggered by a bacterial or viral infection, vaccination, or surgery. During the SARS-CoV-2 pandemic, some patients were reported with GBS associated COVID-19 infection. Case Presentation: We report, herein, a patient who had a recurrent GBS after forty years. Intravenous immunoglobulins (IVIg) induced improvement, but her condition worsened suddenly after twenty days, coinciding with a COVID-19 infection. A second IVIg cycle was administered, and she improved again. Conclusion: The take-home message is that in the current pandemic, any re-worsening or lack of improvement after appropriate treatment of GBS or possibly other autoimmune neurological diseases must be checked to determine if it is related to COVID-19 infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom